and RYSE

Hey 360 – here are some of our top movers today!

🧨 Special Invite Only Event, TODAY (NOW) starting at 9am. Watch to see if JW can call out another 50% SPY options runner and learn how he’s finding these gems. Please register here for access to the trading room!

FOCUS LIST🔎

SCNI – Up over 19% in the pre-market after announcing $10 million standby equity purchase agreement 

IVVD – Up over 9% in pre after announced continued neutralizing activity of PEMGARDA™ (pemivibart) against currently dominant SARS-CoV-2 variant LP.8.1

BRN – Up over 12% in pre after announcing it has entered into a non-binding letter of intent for the sale of its water well drilling subsidiary

*sponsored by 1440 Media

Looking for unbiased, fact-based news? Join 1440 today.

Join over 4 million Americans who start their day with 1440 – your daily digest for unbiased, fact-centric news. From politics to sports, we cover it all by analyzing over 100 sources. Our concise, 5-minute read lands in your inbox each morning at no cost. Experience news without the noise; let 1440 help you make up your own mind. Sign up now and invite your friends and family to be part of the informed.

Subscribe to 1440 today.

HOTLIST🔥

SCNI – Up over 19% in the pre-market after announcing $10 million standby equity purchase agreement

Scinai Immunotherapeutics Ltd. (SCNI) is a development stage biopharmaceutical company that focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.

In the pre-market, the company announced that it has entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, Ltd. (“Yorkville”), a fund managed by Yorkville Advisors Global, LP.

Under the terms of the SEPA, Scinai has the right, but not the obligation, to sell up to $10 million (the “Commitment Amount”) of its American Depository Shares (“ADSs”), each representing 4,000 ordinary shares, to Yorkville at any time during the three-year period following the execution date of the SEPA and following the effectiveness of a registration statement filed with the Securities and Exchange Commission registering the ordinary shares represented by the ADSs issuable pursuant to the SEPA. 

Sales to Yorkville under the SEPA are subject to a beneficial ownership cap of 9.99% of Scinai’s share capital at any one time, along with other restrictions and conditions outlined in the SEPA.

Shares of SCNI traded up over 19% in the pre-market in reaction to the news.

The first target for bull is the pre-market high at $4.09. Beyond that, $4.30, $4.43 and $4.70 come into play.

Below $4.09, targets to the downside are, $3.54, a gap fill at $3.34 with $3.24 below that.

IVVD – Up over 9% in pre after announced continued neutralizing activity of PEMGARDA™ (pemivibart) against currently dominant SARS-CoV-2 variant LP.8.

Invivyd Inc. (IVVD) is a commercial-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

In the pre-market this morning, the company announced positive, continued, clinically meaningful in vitro neutralization data for PEMGARDA™ (pemivibart) against the currently dominant LP.8.1 variant of SARS-CoV-2.

Highlights Include:

• Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together constitute the majority of current national SARS-CoV-2 variants; current dominant variants are all susceptible to PEMGARDA

• Pemivibart antiviral activity remains within the range of expected assay variability since Omicron BA.2; affirms structural biology within Invivyd’s unique technology and reflects consistently stable epitope for pemivibart

• VYD2311 also demonstrates stable epitope and clinically meaningful in vitro neutralization against LP.8.1

• Data provided to U.S. FDA, with update to PEMGARDA Fact Sheet for Healthcare Providers anticipated

Shares of IVVD traded up over 9% in the pre-market in reaction to the news.

The first target for bulls is the pre-market high at $1.27. Beyond that, $1.40, $1.70, $2 and $2.74 come into play.

Below $1.27, targets to the downside are $1.10, a gap fill at $1.05 then $1 and $0.96.

BRN – Up over 12% in pre after announcing it has entered into a non-binding letter of intent for the sale of its water well drilling subsidiary

Barnwell Industries Inc. (BRN) together with its subsidiaries, acquires and develops crude oil and natural gas assets in Canada.

In the pre-market this morning, the company announced that it had entered into a non-binding letter of intent for the sale of Water Resources International, Inc., its water well drilling subsidiary. 

The Company anticipates that the transaction, for an expected aggregate value of $1,050,000, would close in late March 2025. A portion of the consideration would be paid at the closing and the remainder would be paid in installments, with the last installment payable on September 15, 2025, before the end of the Company’s current fiscal year.

The market capitalization of BRN was $13.77 million based on yesterday’s close according to Finviz.

Shares of BRN traded up over 12% in the pre-market in reaction to the news.

The first target for bulls is the pre-market high at $1.65. Beyond that, $1.74, $1.84, $1.89 and $2 come into play.

Below $1.65, targets to the downside are $1.54 and then a gap fill at $1.37 with $1.28 below that.

MARKET NEWS 📰

Don’t miss out on our MOBILE ALERTS!  Some of these alerts have rocketed 🚀past the MOON 🌝.  Text “RAGE” to 1-(888) 487-1534 📲.

*Disclosure: By texting “Alerts” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.